Quarterly ResultMay 15, 2026, 03:27 PM
VSee Health Q1 Net Loss Narrows to $2.6M; Going Concern Doubt
AI Summary
VSee Health reported a net loss of $2.60 million for the first quarter of 2026, an improvement from a $3.96 million loss in the prior year period. However, total revenues decreased to $3.16 million from $3.32 million year-over-year, and the company's cash balance significantly declined. Management has raised substantial doubt about the company's ability to continue as a going concern due to liquidity conditions and historical operating losses, despite ongoing efforts to secure new contracts and additional financing.
Key Highlights
- Q1 2026 net loss narrowed to $2.60 million from $3.96 million in Q1 2025.
- Total revenues for Q1 2026 decreased to $3.16 million from $3.32 million in Q1 2025.
- Gross margin for Q1 2026 was $1.20 million, down from $1.86 million in Q1 2025.
- Operating expenses increased to $4.17 million in Q1 2026 from $3.69 million in Q1 2025.
- Cash balance as of March 31, 2026, was $1.35 million, a significant drop from $5.27 million at Dec 31, 2025.
- Accumulated deficit reached $85.02 million as of March 31, 2026.
- Net cash used in operating activities for Q1 2026 was $(2.45) million, up from $(0.44) million in Q1 2025.
- Basic and diluted loss per share for Q1 2026 was $(0.05), an improvement from $(0.24) in Q1 2025.
Price Impact
More from VSEE